Creek K E, Walter V P, Evers D, Yeo E, Elliott W L, Heinstein P F, Morré D M, Morré D J
Biochim Biophys Acta. 1984 Apr 18;793(2):133-40. doi: 10.1016/0005-2760(84)90314-x.
Previous studies indicated a reproducible pattern of altered glycosphingolipid biosynthesis accompanying late stages of liver tumorigenesis in the rat induced by the carcinogen 2-acetylaminofluorene. The sequence began with a dramatic elevation in CMP-sialic acid:lactosylceramide sialyltransferase and was followed by sequential elevations and eventual depressions in other enzymes catalyzing sugar transfers to glycolipid acceptors. The present study focused on the early events of glycolipid biosynthesis during the first 11 weeks of 2-acetylaminofluorene administration according to the same feeding schedule as used previously. Transient elevations in CMP-sialic acid synthetase and elevations in neutral glycosphingolipid precursors to gangliosides were found to precede the major elevations in CMP-sialic acid:lactosylceramide sialyltransferase (GM3 synthetase) noted earlier. Two cycles of response were observed prior to the initiation of the sustained enhancement of biosynthesis of precursor ganglioside, GM3, and/or a significant increase in total or lipid-soluble sialic acid. In vitro rates of sialyl transfer from CMP-sialic acid to endogenous protein acceptors were not altered. The results suggest that the previous observations of altered ganglioside biosynthesis following 2-acetylaminofluorene administration are not an isolated occurrence but may represent late events in a sequence or 'cascade' of biochemical change involving, as well, biosynthesis of ganglioside precursors, CMP-sialic acid and neutral glycosphingolipids.
先前的研究表明,在由致癌物2-乙酰氨基芴诱导的大鼠肝癌发生后期,糖鞘脂生物合成存在可重复的变化模式。该序列始于CMP-唾液酸:乳糖基神经酰胺唾液酸转移酶的显著升高,随后是催化糖转移至糖脂受体的其他酶的相继升高及最终降低。本研究根据与先前相同的喂养方案,聚焦于2-乙酰氨基芴给药后前11周内糖脂生物合成的早期事件。发现CMP-唾液酸合成酶的短暂升高以及神经节苷脂中性糖鞘脂前体的升高先于先前所述的CMP-唾液酸:乳糖基神经酰胺唾液酸转移酶(GM3合成酶)的主要升高。在持续增强前体神经节苷脂GM3的生物合成及总唾液酸或脂溶性唾液酸显著增加开始之前,观察到两个反应周期。从CMP-唾液酸向内源蛋白受体的唾液酸转移体外速率未改变。结果表明,先前关于2-乙酰氨基芴给药后神经节苷脂生物合成改变的观察并非孤立事件,而是可能代表了一系列生化变化序列或“级联”中的后期事件,这些变化还涉及神经节苷脂前体、CMP-唾液酸和中性糖鞘脂的生物合成。